The mean age of patients with RPE65 mutations was 16.4 ± 12.59 years (median, 10 years), and the mean BCVA was 0.82 ± 0.92 LogMAR with LCA patients and 0.37 ± 1.05 LogMAR with RP patients. This evidence concerns the gene RPE65 and Leber congenital amaurosis.